Early diagnosis of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders

Patent number:

EP22383245

Comunidad de Madrid.svg
No items found.

An in vitro fluorescent method for early detection of Amyotrophic Lateral Sclerosis (ALS) and other TDP-43 related proteinopathies, such as Fronto Temporal Lobar Degeneration (FTLD), based on detection of pathological aggregates of TDP-43 present in cerebrospinal fluid

Countries:
Spain
Regions:
Community of Madrid
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Los polipéptidos de TDP-43 oxidados desarrollados son fáciles de producir y exhiben mayor homogeneidad, estabilidad y selectividad que los péptidos de TDP-43 no modificados. Aplicación para la detección de la ELA y otros trastornos neurodegenerativos, como la DLFT, ELA-DLFT, la enfermedad de Alzheimer o la enfermedad de Parkinson. Método útil para el cribado de compuestos útiles para tratar o prevenir las proteinopatías por TDP-43.

Comments

Other related patents

Health

ANTIMALARIAL AGENT, METHODS AND USES THEREOF

Countries
Portugal
Know more
Food & Agro
New & Sustainable Materials
Health

SYSTEM AND METHOD FOR GENERATING MONODISPERSE MICROBUBBLES IN A CO-FLOW CONFIGURATION

Countries
Spain
Know more
Health
Chemicals

MONONUCLEAR COMPOUND BASED ON RUTHENIUM (III) WITH ANTITUMOR ACTIVITY

Countries
Spain
Know more
Get back to patents directory